Review




Structured Review

Proteintech acc
AMPK inhibition completely abolishes <t>CCR5-mediated</t> <t>GPX4</t> maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated <t>ACC</t> (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Acc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 214 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/ACC1+Antibody/pmc13657224-175-56-57
Average 96 stars, based on 214 article reviews
acc - by Bioz Stars, 2026-10
96/100 stars

Images

1) Product Images from "CCR5 protects against permanent brain ischemia by suppressing neuronal ferroptosis through AMPK/ACC signaling"

Article Title: CCR5 protects against permanent brain ischemia by suppressing neuronal ferroptosis through AMPK/ACC signaling

Journal: Neurotherapeutics

doi: 10.1016/j.neurot.2026.e01088

AMPK inhibition completely abolishes CCR5-mediated GPX4 maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated ACC (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Figure Legend Snippet: AMPK inhibition completely abolishes CCR5-mediated GPX4 maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated ACC (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Techniques Used: Inhibition, Cell Culture, Western Blot, Phospho-proteomics, Expressing, Control

Related Articles

other:

Article Title: Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD/MASH.
Article Snippet: ATP-citrate lyase (ACLY) has emerged as a promising therapeutic target for metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatohepatitis (MASH).. Inspired by the common pharmacophore of natural ACLY inhibitors, we designed and synthesized a novel series of chalconeskeleton derivatives.. Extensive structure-activity relationship (SAR) studies revealed that introducing conformational constraint, particularly through five-membered ring formation (e.g., compound B1) or a rigid benzofuran scaffold (e.g., compound C1), remarkably enhanced ACLY inhibition.

Article Title: Integrated Proteomics and Metabolomics Reveal the Direct Hepatic Protection of Propionate Against Alcoholic Liver Disease via the RGN-PPARα Pathway.
Article Snippet: Primary antibodies, including β-actin (#66009-1-Ig), CPT1A (#15184-1-AP), SREBP-1 (#14088-1-AP), ACC1 (#21923-1-AP), ACOX1 (#83731-2-RR), PPARα (#66826-1-Ig) and RGN (#17947-1-AP), were obtained from Proteintech Group (Wuhan, China).

Article Title: Integrated Proteomics and Metabolomics Reveal the Direct Hepatic Protection of Propionate Against Alcoholic Liver Disease via the RGN-PPARα Pathway
Article Snippet: Primary antibodies, including β-actin (#66009-1-Ig), CPT1A (#15184-1-AP), SREBP-1 (#14088-1-AP), ACC1 (#21923-1-AP), ACOX1 (#83731-2-RR), PPARα (#66826-1-Ig) and RGN (#17947-1-AP), were obtained from Proteintech Group (Wuhan, China).

Article Title: Ganoderic Acid A Alleviates NAFLD by Facilitating PPARα-CPT1A Complex and Enhancing Gut Microbiota Diversity
Article Snippet: Proteins were transferred to PVDF membranes at a constant current of 250 mA for 2 hours using a transfer apparatus from DLAB Scientific Co., Ltd (Cat#18901229).

Incubation:

Article Title: Macrophage-derived IL-6 reprograms lipid metabolism to promote colorectal cancer development through USP14-mediated FASN deubiquitination
Article Snippet: The proteins were transferred to PVDF membranes (Cat#03010040001; Merck Millipore, Massachusetts, USA). .. The membranes were blocked in TBST containing 5% nonfat milk for 1 h at room temperature and incubated overnight with primary antibodies against FASN (Cat#10624-2-AP, Proteintech), USP14 (Cat#14517-1-AP, Proteintech), SREBP1 (Cat#14088-1-AP, Proteintech), ACC1 (Cat#21923-1-AP, Proteintech), SCD1 (Cat#28678-1-AP, Proteintech), ACLY (Cat#15421-1-AP, Proteintech) and β-actin (Cat#66009-1-Ig, Proteintech), followed by incubation with an HRP-labeled secondary antibody. .. The protein bands were visualized with Immobilon Western HRP substrate (Cat# WBKLS0100, Merck Millipore) and captured via a Tanon Scanning System (Shanghai, China).



Similar Products

94
ABclonal Biotechnology phospho acc1 s79
Phospho Acc1 S79, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/Phospho-ACC1-S79+Rabbit+pAb/pm42894543-294-31-34
Average 94 stars, based on 1 article reviews
phospho acc1 s79 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
Proteintech acc
AMPK inhibition completely abolishes <t>CCR5-mediated</t> <t>GPX4</t> maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated <t>ACC</t> (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Acc, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/ACC1+Antibody/pmc13657224-175-56-57
Average 96 stars, based on 1 article reviews
acc - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
ABclonal Biotechnology rabbit pab against p acc1
AMPK inhibition completely abolishes <t>CCR5-mediated</t> <t>GPX4</t> maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated <t>ACC</t> (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Rabbit Pab Against P Acc1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/Phospho-ACC1-S79+Rabbit+pAb/pm41850133-54-8-23
Average 94 stars, based on 1 article reviews
rabbit pab against p acc1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

92
ABclonal Biotechnology rabbit mab against acc1
AMPK inhibition completely abolishes <t>CCR5-mediated</t> <t>GPX4</t> maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated <t>ACC</t> (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Rabbit Mab Against Acc1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/SMARCC2+Rabbit+pAb/pm41850133-54-2-23
Average 92 stars, based on 1 article reviews
rabbit mab against acc1 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc acc1
AMPK inhibition completely abolishes <t>CCR5-mediated</t> <t>GPX4</t> maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated <t>ACC</t> (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Acc1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/Acetyl-CoA+Carboxylase+Rabbit+mAb/pm41632836-30-38-39
Average 96 stars, based on 1 article reviews
acc1 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Thermo Fisher anti acc1
AMPK inhibition completely abolishes <t>CCR5-mediated</t> <t>GPX4</t> maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated <t>ACC</t> (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Anti Acc1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/Sphingosine-1-phosphate/pm42230631-491-0-1
Average 95 stars, based on 1 article reviews
anti acc1 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
ABclonal Biotechnology phospho acc1
Lipolysis and mitophagy signaling in iWAT of CPF-exposed (2 mg/kg BW) male mice upon prolonged weight loss. C57BL/6J male mice were fed a HFD (60%), gavaged with 2 mg/kg BW CPF (or saline) daily for 1 month, and then subjected to weight loss programs through treadmill exercise or CL316243 injections, for a period of 10 weeks. (A) Western blot bands of AMPKα and p-AMPKα in iWAT. (B, C) Quantification of AMPKα (B) and p-AMPKα (C) proteins in iWAT. (D) Western blot bands of HSL and p- HSL in iWAT. (E, F) Quantification of HSL (E) and p- HSL (F) proteins in iWAT. (G) Western blot bands of <t>ACC1</t> and p-ACC1 in iWAT. (H, I) Quantification of ACC1 (H) and p-ACC1 (I) proteins in iWAT. (J) Western blot bands of p-PKA in iWAT. (K) Quantification of p-PKA protein in iWAT. (L) Western blot bands of ULK1, p-ULK1 and P62 in iWAT. (M–O) Quantification of ULK1 (M), p-ULK1 (N), and P62 (O) proteins in iWAT. The underlying data of B, C, E, F, H, I, K, M, N, and O are available in Table S17 . Data presented are mean ± SEM, n = 6. Variances were analyzed by one-way ANOVA, and pairwise comparisons were performed using Fisher’s LSD procedure. * p < 0.05, ** p < 0.01, *** p < 0.001. iWAT, inguinal white adipose tissue.CPF: chlorpyrifos.iWAT: inguinal white adipose tissue.AMPKα: AMP-activated protein kinase α; p-AMPKα: phosphorylated AMP-activated protein kinase α; HSL: lipolytic protein hormone-sensitive lipase. p-HSL: phosphorylated lipolytic protein hormone-sensitive lipase. ACC1: acetyl-CoA carboxylase 1. p-ACC1: phosphorylated acetyl-CoA carboxylase 1. p-PKA: phosphorylated protein kinase A. ULK1: unc-51-like autophagy-activated kinase 1. p-ULK1: phosphorylated unc-51-like autophagy-activated kinase 1. P62: sequestosome 1.
Phospho Acc1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/Phospho-ACC1-S79+Rabbit+pAb/pmc13347641-133-7-27
Average 94 stars, based on 1 article reviews
phospho acc1 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
Proteintech acc1
Lipolysis and mitophagy signaling in iWAT of CPF-exposed (2 mg/kg BW) male mice upon prolonged weight loss. C57BL/6J male mice were fed a HFD (60%), gavaged with 2 mg/kg BW CPF (or saline) daily for 1 month, and then subjected to weight loss programs through treadmill exercise or CL316243 injections, for a period of 10 weeks. (A) Western blot bands of AMPKα and p-AMPKα in iWAT. (B, C) Quantification of AMPKα (B) and p-AMPKα (C) proteins in iWAT. (D) Western blot bands of HSL and p- HSL in iWAT. (E, F) Quantification of HSL (E) and p- HSL (F) proteins in iWAT. (G) Western blot bands of <t>ACC1</t> and p-ACC1 in iWAT. (H, I) Quantification of ACC1 (H) and p-ACC1 (I) proteins in iWAT. (J) Western blot bands of p-PKA in iWAT. (K) Quantification of p-PKA protein in iWAT. (L) Western blot bands of ULK1, p-ULK1 and P62 in iWAT. (M–O) Quantification of ULK1 (M), p-ULK1 (N), and P62 (O) proteins in iWAT. The underlying data of B, C, E, F, H, I, K, M, N, and O are available in Table S17 . Data presented are mean ± SEM, n = 6. Variances were analyzed by one-way ANOVA, and pairwise comparisons were performed using Fisher’s LSD procedure. * p < 0.05, ** p < 0.01, *** p < 0.001. iWAT, inguinal white adipose tissue.CPF: chlorpyrifos.iWAT: inguinal white adipose tissue.AMPKα: AMP-activated protein kinase α; p-AMPKα: phosphorylated AMP-activated protein kinase α; HSL: lipolytic protein hormone-sensitive lipase. p-HSL: phosphorylated lipolytic protein hormone-sensitive lipase. ACC1: acetyl-CoA carboxylase 1. p-ACC1: phosphorylated acetyl-CoA carboxylase 1. p-PKA: phosphorylated protein kinase A. ULK1: unc-51-like autophagy-activated kinase 1. p-ULK1: phosphorylated unc-51-like autophagy-activated kinase 1. P62: sequestosome 1.
Acc1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/FASN+Antibody/pm41922122-296-10-12
Average 96 stars, based on 1 article reviews
acc1 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Proteintech rat anti acc1 antibody
Lipolysis and mitophagy signaling in iWAT of CPF-exposed (2 mg/kg BW) male mice upon prolonged weight loss. C57BL/6J male mice were fed a HFD (60%), gavaged with 2 mg/kg BW CPF (or saline) daily for 1 month, and then subjected to weight loss programs through treadmill exercise or CL316243 injections, for a period of 10 weeks. (A) Western blot bands of AMPKα and p-AMPKα in iWAT. (B, C) Quantification of AMPKα (B) and p-AMPKα (C) proteins in iWAT. (D) Western blot bands of HSL and p- HSL in iWAT. (E, F) Quantification of HSL (E) and p- HSL (F) proteins in iWAT. (G) Western blot bands of <t>ACC1</t> and p-ACC1 in iWAT. (H, I) Quantification of ACC1 (H) and p-ACC1 (I) proteins in iWAT. (J) Western blot bands of p-PKA in iWAT. (K) Quantification of p-PKA protein in iWAT. (L) Western blot bands of ULK1, p-ULK1 and P62 in iWAT. (M–O) Quantification of ULK1 (M), p-ULK1 (N), and P62 (O) proteins in iWAT. The underlying data of B, C, E, F, H, I, K, M, N, and O are available in Table S17 . Data presented are mean ± SEM, n = 6. Variances were analyzed by one-way ANOVA, and pairwise comparisons were performed using Fisher’s LSD procedure. * p < 0.05, ** p < 0.01, *** p < 0.001. iWAT, inguinal white adipose tissue.CPF: chlorpyrifos.iWAT: inguinal white adipose tissue.AMPKα: AMP-activated protein kinase α; p-AMPKα: phosphorylated AMP-activated protein kinase α; HSL: lipolytic protein hormone-sensitive lipase. p-HSL: phosphorylated lipolytic protein hormone-sensitive lipase. ACC1: acetyl-CoA carboxylase 1. p-ACC1: phosphorylated acetyl-CoA carboxylase 1. p-PKA: phosphorylated protein kinase A. ULK1: unc-51-like autophagy-activated kinase 1. p-ULK1: phosphorylated unc-51-like autophagy-activated kinase 1. P62: sequestosome 1.
Rat Anti Acc1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/ACC1+Antibody/pm41903408-241-9-13
Average 96 stars, based on 1 article reviews
rat anti acc1 antibody - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Proteintech acaca
<t>ACACA</t> mediates the pro‐inflammatory action <t>of</t> <t>ZXDB</t> on macrophages. (A) Overlap of ZXDB‐regulated genes/proteins and ACACA‐interacting proteins. (B) Protein–protein interaction network showing ACACA's association with the ZXDB network. (C) ACACA mRNA expression in THP‐1 cells, treated with LPS (100 ng/mL) +/− shZxdb for 6 h. (D) ACACA protein expression in THP‐1 cells, treated as in (C). (E–H) Cell proliferation (E, G) and apoptosis (F, H) in RAW264.7 (E, F) and THP‐1 cells (G, H) subjected to rescue experiments (LPS +/− shZxdb +/− Acaca overexpression). (I‐J) M1‐like (CD86 + INOS + ), M2a‐like (CD206 + ARG1 + ), and M2b‐like (CD86 + IL‐10 + ) macrophage populations in RAW264.7 (I) and THP‐1 cells (J) from the rescue experiments. (K‐L) Cytokine secretion (TNF‐α, IFN‐γ, IL‐1β, IL‐10, IL‐4, IL‐13) in RAW264.7 (K) and THP‐1 cell supernatants from the rescue experiments. (M‐P) Relative ATP levels (M, N) and lactate production (O, P) in RAW264.7 (M, O) and THP‐1 cells (N, P) from the rescue experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.
Acaca, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/acc1/ACC1+Antibody/pmc13011163-85-15-17
Average 96 stars, based on 1 article reviews
acaca - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


AMPK inhibition completely abolishes CCR5-mediated GPX4 maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated ACC (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Journal: Neurotherapeutics

Article Title: CCR5 protects against permanent brain ischemia by suppressing neuronal ferroptosis through AMPK/ACC signaling

doi: 10.1016/j.neurot.2026.e01088

Figure Lengend Snippet: AMPK inhibition completely abolishes CCR5-mediated GPX4 maintenance and anti-ferroptotic protection. (A–B) SH-SY5Y cells were treated with the AMPK inhibitor Compound C (COC, 10 μM) and cultured under hypoxia-ischemia-mimicking conditions. Representative western blots (A) and quantitative analyses (B) of phosphorylated AMPK (p-AMPK), total AMPK, phosphorylated ACC (p-ACC), total ACC, and the corresponding phosphorylation ratios were shown. (C–E) Under the same experimental conditions, representative western blots (C) and quantitative analyses (D) of CCR5 and GPX4 protein expression, together with MDA levels (E), were shown. β-Tubulin or β-actin were used as a loading control. Data are presented as mean ± SD (n = 3). Statistical analyses were performed using one-way ANOVA followed by Fisher's LSD post hoc tests. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Article Snippet: Following electrophoretic separation, the proteins were transferred onto a nitrocellulose membrane, which was then blocked with 5% skimmed milk at room temperature for 1 h. The membrane was incubated overnight at 4 °C with primary antibodies against HIF-1α (ABclonal Technology, A24002), CCR5 (Affinity Biosciences LTD, AF6339), Phospho-AMPKα (Thr172) (Beyotime, AA393), AMPKα (Proteintech, 10929-2-AP), Phospho-ACC (Proteintech, 29119-1-AP), ACC (Proteintech, 21923-1-AP), or GPX4 (Abmart, T56959 ), each diluted to a ratio of 1:1000 in 5% bovine serum albumin (BSA).

Techniques: Inhibition, Cell Culture, Western Blot, Phospho-proteomics, Expressing, Control

Lipolysis and mitophagy signaling in iWAT of CPF-exposed (2 mg/kg BW) male mice upon prolonged weight loss. C57BL/6J male mice were fed a HFD (60%), gavaged with 2 mg/kg BW CPF (or saline) daily for 1 month, and then subjected to weight loss programs through treadmill exercise or CL316243 injections, for a period of 10 weeks. (A) Western blot bands of AMPKα and p-AMPKα in iWAT. (B, C) Quantification of AMPKα (B) and p-AMPKα (C) proteins in iWAT. (D) Western blot bands of HSL and p- HSL in iWAT. (E, F) Quantification of HSL (E) and p- HSL (F) proteins in iWAT. (G) Western blot bands of ACC1 and p-ACC1 in iWAT. (H, I) Quantification of ACC1 (H) and p-ACC1 (I) proteins in iWAT. (J) Western blot bands of p-PKA in iWAT. (K) Quantification of p-PKA protein in iWAT. (L) Western blot bands of ULK1, p-ULK1 and P62 in iWAT. (M–O) Quantification of ULK1 (M), p-ULK1 (N), and P62 (O) proteins in iWAT. The underlying data of B, C, E, F, H, I, K, M, N, and O are available in Table S17 . Data presented are mean ± SEM, n = 6. Variances were analyzed by one-way ANOVA, and pairwise comparisons were performed using Fisher’s LSD procedure. * p < 0.05, ** p < 0.01, *** p < 0.001. iWAT, inguinal white adipose tissue.CPF: chlorpyrifos.iWAT: inguinal white adipose tissue.AMPKα: AMP-activated protein kinase α; p-AMPKα: phosphorylated AMP-activated protein kinase α; HSL: lipolytic protein hormone-sensitive lipase. p-HSL: phosphorylated lipolytic protein hormone-sensitive lipase. ACC1: acetyl-CoA carboxylase 1. p-ACC1: phosphorylated acetyl-CoA carboxylase 1. p-PKA: phosphorylated protein kinase A. ULK1: unc-51-like autophagy-activated kinase 1. p-ULK1: phosphorylated unc-51-like autophagy-activated kinase 1. P62: sequestosome 1.

Journal: Environmental Health Perspectives

Article Title: Mobilization of the Environmental Toxicant Chlorpyrifos during Weight Loss and Its Impact on Liver and Adipose Tissue Metabolism in Mice

doi: 10.1021/EHP.6c00042

Figure Lengend Snippet: Lipolysis and mitophagy signaling in iWAT of CPF-exposed (2 mg/kg BW) male mice upon prolonged weight loss. C57BL/6J male mice were fed a HFD (60%), gavaged with 2 mg/kg BW CPF (or saline) daily for 1 month, and then subjected to weight loss programs through treadmill exercise or CL316243 injections, for a period of 10 weeks. (A) Western blot bands of AMPKα and p-AMPKα in iWAT. (B, C) Quantification of AMPKα (B) and p-AMPKα (C) proteins in iWAT. (D) Western blot bands of HSL and p- HSL in iWAT. (E, F) Quantification of HSL (E) and p- HSL (F) proteins in iWAT. (G) Western blot bands of ACC1 and p-ACC1 in iWAT. (H, I) Quantification of ACC1 (H) and p-ACC1 (I) proteins in iWAT. (J) Western blot bands of p-PKA in iWAT. (K) Quantification of p-PKA protein in iWAT. (L) Western blot bands of ULK1, p-ULK1 and P62 in iWAT. (M–O) Quantification of ULK1 (M), p-ULK1 (N), and P62 (O) proteins in iWAT. The underlying data of B, C, E, F, H, I, K, M, N, and O are available in Table S17 . Data presented are mean ± SEM, n = 6. Variances were analyzed by one-way ANOVA, and pairwise comparisons were performed using Fisher’s LSD procedure. * p < 0.05, ** p < 0.01, *** p < 0.001. iWAT, inguinal white adipose tissue.CPF: chlorpyrifos.iWAT: inguinal white adipose tissue.AMPKα: AMP-activated protein kinase α; p-AMPKα: phosphorylated AMP-activated protein kinase α; HSL: lipolytic protein hormone-sensitive lipase. p-HSL: phosphorylated lipolytic protein hormone-sensitive lipase. ACC1: acetyl-CoA carboxylase 1. p-ACC1: phosphorylated acetyl-CoA carboxylase 1. p-PKA: phosphorylated protein kinase A. ULK1: unc-51-like autophagy-activated kinase 1. p-ULK1: phosphorylated unc-51-like autophagy-activated kinase 1. P62: sequestosome 1.

Article Snippet: Primary antibodies against ACC1 (A19627, 1:1000 dilution), Phospho-ACC1 (AP0298, 1:1000 dilution), HSL (A15686, 1:1000 dilution), Phospho-HSL (Ap0853, 1:1000 dilution), and Phospho-ULK1 (AP0760, 1:1000 dilution) were purchased from ABclonal Inc. (Wuhan, China).

Techniques: Saline, Western Blot

ACACA mediates the pro‐inflammatory action of ZXDB on macrophages. (A) Overlap of ZXDB‐regulated genes/proteins and ACACA‐interacting proteins. (B) Protein–protein interaction network showing ACACA's association with the ZXDB network. (C) ACACA mRNA expression in THP‐1 cells, treated with LPS (100 ng/mL) +/− shZxdb for 6 h. (D) ACACA protein expression in THP‐1 cells, treated as in (C). (E–H) Cell proliferation (E, G) and apoptosis (F, H) in RAW264.7 (E, F) and THP‐1 cells (G, H) subjected to rescue experiments (LPS +/− shZxdb +/− Acaca overexpression). (I‐J) M1‐like (CD86 + INOS + ), M2a‐like (CD206 + ARG1 + ), and M2b‐like (CD86 + IL‐10 + ) macrophage populations in RAW264.7 (I) and THP‐1 cells (J) from the rescue experiments. (K‐L) Cytokine secretion (TNF‐α, IFN‐γ, IL‐1β, IL‐10, IL‐4, IL‐13) in RAW264.7 (K) and THP‐1 cell supernatants from the rescue experiments. (M‐P) Relative ATP levels (M, N) and lactate production (O, P) in RAW264.7 (M, O) and THP‐1 cells (N, P) from the rescue experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: The FASEB Journal

Article Title: ZXDB Drives Macrophage Inflammatory Programming in Sepsis‐Induced Acute Kidney Injury by Recruiting EIF4A3 to Enhance ACACA Translation

doi: 10.1096/fj.202502962RR

Figure Lengend Snippet: ACACA mediates the pro‐inflammatory action of ZXDB on macrophages. (A) Overlap of ZXDB‐regulated genes/proteins and ACACA‐interacting proteins. (B) Protein–protein interaction network showing ACACA's association with the ZXDB network. (C) ACACA mRNA expression in THP‐1 cells, treated with LPS (100 ng/mL) +/− shZxdb for 6 h. (D) ACACA protein expression in THP‐1 cells, treated as in (C). (E–H) Cell proliferation (E, G) and apoptosis (F, H) in RAW264.7 (E, F) and THP‐1 cells (G, H) subjected to rescue experiments (LPS +/− shZxdb +/− Acaca overexpression). (I‐J) M1‐like (CD86 + INOS + ), M2a‐like (CD206 + ARG1 + ), and M2b‐like (CD86 + IL‐10 + ) macrophage populations in RAW264.7 (I) and THP‐1 cells (J) from the rescue experiments. (K‐L) Cytokine secretion (TNF‐α, IFN‐γ, IL‐1β, IL‐10, IL‐4, IL‐13) in RAW264.7 (K) and THP‐1 cell supernatants from the rescue experiments. (M‐P) Relative ATP levels (M, N) and lactate production (O, P) in RAW264.7 (M, O) and THP‐1 cells (N, P) from the rescue experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Membranes were then incubated overnight at 4°C with primary antibodies against: ZXDB (A303‐656A; Invitrogen, 1:1000), ACACA (21923‐1‐AP; Proteintech, RRID:AB_11042445, 1:1000), EIF4A3 (17 504‐1‐AP; Proteintech, RRID:AB_2097393, 1:1000), iNOS (22226‐1‐AP; Proteintech, RRID:AB_2879038, 1:1000), CD86 (13395‐1‐AP; Proteintech–, RRID:AB_2074882, 1:1000), ARG1 (16001‐1‐AP; Proteintech–, RRID:AB_2289842, 1:1000), CD206 (18704‐1‐AP; Proteintech, RRID:AB_10597232, 1:1000), GAPDH (60004‐1‐Ig; Proteintech, RRID:AB_2107436, 1:10000).

Techniques: Expressing, Over Expression

ZXDB interacts through its RRM domain with EIF4A3 to stimulate translation of ACACA mRNA. (A) ZXDB IP from THP‐1 cell lysates, followed by SDS‐PAGE and Coomassie staining. (B) Overlap of ZXDB interactors identified by IP‐MS and EIF4A3 interactors. (C) Co‐IP of endogenous ZXDB and EIF4A3 from THP‐1 cells. (D) Co‐IP of Flag‐ZXDB and HA‐EIF4A3, ectopically expressed in THP‐1 cells. (E) Co‐localization of endogenous ZXDB (red) and EIF4A3 (green) in THP‐1 cells by immunofluorescence. (F, G) Effect of EIF4A3 knockdown (shEIF4A) on ACACA mRNA (F) and protein (G) expression. THP‐1 cells transfected with indicated plasmids were analyzed. (H) Polysome profiling of ACACA mRNA in THP‐1 cells transfected with indicated constructs and stimulated with LPS. (I) ACACA 5′UTR‐luciferase reporter assay in THP‐1 cells, treated with indicated plasmids. (J, K) RIP‐qPCR analysis of ACACA mRNA associated with endogenous ZXDB (J) or EIF4A3 (K) in THP‐1 cells. (L) RNA pull‐down assay: EIF4A3 binding to ACACA 5′UTR probe. (M) Schematic of ZXDB and its truncation mutants. (N) Co‐IP of HA‐EIF4A3 with Flag‐tagged ZXDB truncations in HEK293T cells. (O) GST pull‐down assay: Interaction of GST‐ZXDB truncation mutants with His‐EIF4A3. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: The FASEB Journal

Article Title: ZXDB Drives Macrophage Inflammatory Programming in Sepsis‐Induced Acute Kidney Injury by Recruiting EIF4A3 to Enhance ACACA Translation

doi: 10.1096/fj.202502962RR

Figure Lengend Snippet: ZXDB interacts through its RRM domain with EIF4A3 to stimulate translation of ACACA mRNA. (A) ZXDB IP from THP‐1 cell lysates, followed by SDS‐PAGE and Coomassie staining. (B) Overlap of ZXDB interactors identified by IP‐MS and EIF4A3 interactors. (C) Co‐IP of endogenous ZXDB and EIF4A3 from THP‐1 cells. (D) Co‐IP of Flag‐ZXDB and HA‐EIF4A3, ectopically expressed in THP‐1 cells. (E) Co‐localization of endogenous ZXDB (red) and EIF4A3 (green) in THP‐1 cells by immunofluorescence. (F, G) Effect of EIF4A3 knockdown (shEIF4A) on ACACA mRNA (F) and protein (G) expression. THP‐1 cells transfected with indicated plasmids were analyzed. (H) Polysome profiling of ACACA mRNA in THP‐1 cells transfected with indicated constructs and stimulated with LPS. (I) ACACA 5′UTR‐luciferase reporter assay in THP‐1 cells, treated with indicated plasmids. (J, K) RIP‐qPCR analysis of ACACA mRNA associated with endogenous ZXDB (J) or EIF4A3 (K) in THP‐1 cells. (L) RNA pull‐down assay: EIF4A3 binding to ACACA 5′UTR probe. (M) Schematic of ZXDB and its truncation mutants. (N) Co‐IP of HA‐EIF4A3 with Flag‐tagged ZXDB truncations in HEK293T cells. (O) GST pull‐down assay: Interaction of GST‐ZXDB truncation mutants with His‐EIF4A3. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Membranes were then incubated overnight at 4°C with primary antibodies against: ZXDB (A303‐656A; Invitrogen, 1:1000), ACACA (21923‐1‐AP; Proteintech, RRID:AB_11042445, 1:1000), EIF4A3 (17 504‐1‐AP; Proteintech, RRID:AB_2097393, 1:1000), iNOS (22226‐1‐AP; Proteintech, RRID:AB_2879038, 1:1000), CD86 (13395‐1‐AP; Proteintech–, RRID:AB_2074882, 1:1000), ARG1 (16001‐1‐AP; Proteintech–, RRID:AB_2289842, 1:1000), CD206 (18704‐1‐AP; Proteintech, RRID:AB_10597232, 1:1000), GAPDH (60004‐1‐Ig; Proteintech, RRID:AB_2107436, 1:10000).

Techniques: SDS Page, Staining, Protein-Protein interactions, Co-Immunoprecipitation Assay, Immunofluorescence, Knockdown, Expressing, Transfection, Construct, Luciferase, Reporter Assay, Pull Down Assay, Binding Assay

The ZXDB‐EIF4A3 Interaction Is required for Its Pro‐inflammatory Functions. (A) Co‐IP of HA‐EIF4A3 with Flag‐ZXDB or ZXDB‐MUT in THP‐1 cells. (B) ACACA protein expression in THP‐1 cells transfected with the indicated plasmids and treated with LPS for 6 h. (C) Polysome profiling of ACACA mRNA in THP‐1 cells with Flag‐ZXDB or ZXDB‐MUT, stimulated with LPS. (D) RIP‐qPCR analysis of ACACA mRNA associated with ZXDB or ZXDB‐MUT. (E‐F) Cell proliferation (E) and apoptosis (F) in THP‐1 cells transfected and treated with LPS for 6 h. (G) M1‐like (CD86 + INOS + ), M2a‐like (CD206 + ARG1 + ) and M2b‐like (CD86 + IL‐10 + ) populations in THP‐1 cells. (H) M1‐like (iNOS, CD40, CD86, CD80) and M2‐like (CD206, CD163, ARG1) protein expression in THP‐1 cells. (I) Cytokine secretion (IFN‐γ, TNF‐α, IL‐6, IL‐1β, IL‐4, IL‐13, IL‐10) in THP‐1 cell supernatants. * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: The FASEB Journal

Article Title: ZXDB Drives Macrophage Inflammatory Programming in Sepsis‐Induced Acute Kidney Injury by Recruiting EIF4A3 to Enhance ACACA Translation

doi: 10.1096/fj.202502962RR

Figure Lengend Snippet: The ZXDB‐EIF4A3 Interaction Is required for Its Pro‐inflammatory Functions. (A) Co‐IP of HA‐EIF4A3 with Flag‐ZXDB or ZXDB‐MUT in THP‐1 cells. (B) ACACA protein expression in THP‐1 cells transfected with the indicated plasmids and treated with LPS for 6 h. (C) Polysome profiling of ACACA mRNA in THP‐1 cells with Flag‐ZXDB or ZXDB‐MUT, stimulated with LPS. (D) RIP‐qPCR analysis of ACACA mRNA associated with ZXDB or ZXDB‐MUT. (E‐F) Cell proliferation (E) and apoptosis (F) in THP‐1 cells transfected and treated with LPS for 6 h. (G) M1‐like (CD86 + INOS + ), M2a‐like (CD206 + ARG1 + ) and M2b‐like (CD86 + IL‐10 + ) populations in THP‐1 cells. (H) M1‐like (iNOS, CD40, CD86, CD80) and M2‐like (CD206, CD163, ARG1) protein expression in THP‐1 cells. (I) Cytokine secretion (IFN‐γ, TNF‐α, IL‐6, IL‐1β, IL‐4, IL‐13, IL‐10) in THP‐1 cell supernatants. * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: Membranes were then incubated overnight at 4°C with primary antibodies against: ZXDB (A303‐656A; Invitrogen, 1:1000), ACACA (21923‐1‐AP; Proteintech, RRID:AB_11042445, 1:1000), EIF4A3 (17 504‐1‐AP; Proteintech, RRID:AB_2097393, 1:1000), iNOS (22226‐1‐AP; Proteintech, RRID:AB_2879038, 1:1000), CD86 (13395‐1‐AP; Proteintech–, RRID:AB_2074882, 1:1000), ARG1 (16001‐1‐AP; Proteintech–, RRID:AB_2289842, 1:1000), CD206 (18704‐1‐AP; Proteintech, RRID:AB_10597232, 1:1000), GAPDH (60004‐1‐Ig; Proteintech, RRID:AB_2107436, 1:10000).

Techniques: Co-Immunoprecipitation Assay, Expressing, Transfection

Schematic diagram of the proposed mechanism by which ZXDB promotes M1‐like macrophage polarization and exacerbates SI‐AKI. In macrophage, ZXDB interacts with EIF4A3, promoting the translation of the ACACA gene. The resulting increase in ACACA protein expression enhances glycolysis and lactate production. This metabolic reprogramming shifts macrophage polarization toward M1‐like macrophage activation (characterized by increased Cd86, Cd80, Cd40, and iNOS) and away from an anti‐inflammatory M2‐like phenotype (characterized by Cd206, Cd163, and Arg1). The dominance of M1‐like macrophages leads to an elevated secretion of pro‐inflammatory cytokines (TNF‐α, IFN‐γ, IL‐1β) and reduced anti‐inflammatory cytokines (IL‐10, IL‐4, IL‐13), which collectively drive the pathogenesis of acute kidney injury.

Journal: The FASEB Journal

Article Title: ZXDB Drives Macrophage Inflammatory Programming in Sepsis‐Induced Acute Kidney Injury by Recruiting EIF4A3 to Enhance ACACA Translation

doi: 10.1096/fj.202502962RR

Figure Lengend Snippet: Schematic diagram of the proposed mechanism by which ZXDB promotes M1‐like macrophage polarization and exacerbates SI‐AKI. In macrophage, ZXDB interacts with EIF4A3, promoting the translation of the ACACA gene. The resulting increase in ACACA protein expression enhances glycolysis and lactate production. This metabolic reprogramming shifts macrophage polarization toward M1‐like macrophage activation (characterized by increased Cd86, Cd80, Cd40, and iNOS) and away from an anti‐inflammatory M2‐like phenotype (characterized by Cd206, Cd163, and Arg1). The dominance of M1‐like macrophages leads to an elevated secretion of pro‐inflammatory cytokines (TNF‐α, IFN‐γ, IL‐1β) and reduced anti‐inflammatory cytokines (IL‐10, IL‐4, IL‐13), which collectively drive the pathogenesis of acute kidney injury.

Article Snippet: Membranes were then incubated overnight at 4°C with primary antibodies against: ZXDB (A303‐656A; Invitrogen, 1:1000), ACACA (21923‐1‐AP; Proteintech, RRID:AB_11042445, 1:1000), EIF4A3 (17 504‐1‐AP; Proteintech, RRID:AB_2097393, 1:1000), iNOS (22226‐1‐AP; Proteintech, RRID:AB_2879038, 1:1000), CD86 (13395‐1‐AP; Proteintech–, RRID:AB_2074882, 1:1000), ARG1 (16001‐1‐AP; Proteintech–, RRID:AB_2289842, 1:1000), CD206 (18704‐1‐AP; Proteintech, RRID:AB_10597232, 1:1000), GAPDH (60004‐1‐Ig; Proteintech, RRID:AB_2107436, 1:10000).

Techniques: Expressing, Activation Assay